Dorsal Penile Nerve Block for Rigid Cystoscopy in Men

NCT02502487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2020-03-31

Study results available
· View outcomes & findings →

Summary

This study will determine the effectiveness and safety of dorsal penile nerve block (DPNB) in men undergoing rigid cystoscopy.

Conditions

Interventions

PROCEDURE

Dorsal Penile Nerve Block

Dorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis

DRUG

Ropivacaine

0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis

DRUG

Tetracaine

1% Tetracaine gel instilled into urethra

Sponsors & Collaborators

  • West China Hospital

    lead OTHER

Principal Investigators

  • Guizhi Du, Doctor · West China Hospital of Sichuan University, Department of Anesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02502487 on ClinicalTrials.gov